Tamoxifen-induced regression of breast cysts

Clinical Imaging

Volumn 22, Issue 2, 1998, Pages 95-98

  Hurst, Janis L ^a,b   Mega, John F ^a   Hogg, Jeffery P ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign breast disease; Breast cysts; Cystic disease of breast; Mammography; Tamoxifen; Ultrasound

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; BREAST CYST; CASE REPORT; FEMALE; HUMAN; MAMMOGRAPHY; PARENCHYMA;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; TAMOXIFEN;

EID: 0032031522     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-7071(97)00076-4     Document Type: Article

References (15)

1. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 196:1995;433-437.
2. McNicholas MMJ, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP Pain and increased mammographic density in women receiving hormone replacement therapy. a prospective study AJR. 163:1994;311-315.
3. Hulka BS Links between hormone replacement therapy and neoplasia. Fertility and Sterility. 62(6):1994;168S-175S.
4. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE Mammographic changes associated with postmenopausal hormone replacement therapy. a longitudinal study Radiology. 174:1990;487-490.
5. Ricciardi I, Ianniruberto A Tamoxifen-induced regression of benign breast lesions. Obstet and Gynecol. 54:1979;80-84.
6. Shaaban MM, Morad F, Hassan AERR Treatment of fibrocystic mastopathy by an antiestrogen, Tamoxifen. Int J Cynec Obstet. 18:1980;348-359.
7. Heel RC, Brodgen RN, Speight TM, Avery GS Tamoxifen. a review of its pharmacological properties and therapeutic use in the treatment of breast cancer Australian Drug Information Services Drugs. 16:1978;1-24.
8. Taylor C, Georgian-Smith D Regression of breast cancer in four patients treated with Tamoxifen. mammographic features AJR. 162:1994;613-616.
9. Fentiman IS, Brame K, Caleffi M, Chaudary MA, Hayward JL. Double-blind controlled trial of Tamoxifen therapy for mastalgia. Lancet 1986;i(8476):287-289.
10. Fentiman IS, Powles TJ. Tamoxifen and benign breast problems. Lancet 1987;i(8567):1070-1072.
11. Kopans DB Breast Imaging. 1989;J.B. Lippincott Company, Philadelphia.
12. Peters ME, Voegeli DR, Scanlan KA Breast Imaging. 1989;Churchill Livingstone, New York.
13. Cohen I, Rosen DJD, Shapiro Jet al. Endometrial changes in postmenopausal women treated with Tamoxifen for breast cancer. Brit J Obstetrics and Gynaecology. 100:1993;567-570.
14. O'Neill E, Rodriquez-Mojica W Asymptomatic carcinoma of the endometrium in a patient on adjunctive Tamoxifen therapy for carcinoma of the breast. Bol Assoc Med P Rico. 84(2):1992;74-77.
15. Seoud MA-F, Johnson J, Weed JC Gynecologic tumors in Tamoxifen-treated women with breast cancer. Obstet Gynecol. 82(2):1993;165-169.